why choose us

First received: July 29, 2024

Clinical Trial: Diltiazem in Jervell and Lange-Nielsen Syndrome

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Jervell and Lange Nielsen Syndrome

Study Type: INTERVENTIONAL


Official Title: Diltiazem in Jervell and Lange-Nielsen Syndrome

Brief Summary: This study will test the effect of diltiazem, a calcium channel blocking drug, on the QT interval in patients with Jervell and Lange-Nielsen syndrome.This will be a single IV dose and acute effects (within minutes) will be observed.

Read more